Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhalable Sodium Bicarbonate for COVID-19
NCT05035524Unknown
- Sponsor
- Mansoura University
- Start
- Sep 2021
- Primary completion
- Mar 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of sodium bicarbonate in coronavirus disease 2019 (COVID-19) (2 arms), sponsored by Mansoura University. Primary endpoint: Time to recovery at 28 days. Status: unknown.
02
Drugs
sodium bicarbonate
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05035524.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05035524.